Cargando…

Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer

Speckle-type POZ domain protein (SPOP) has been acknowledged as a tumor suppressor gene in numerous types of cancer. However, SPOP expression and its prognostic role in human non-small cell lung cancer (NSCLC) remain unknown. The present study investigated SPOP expression in NSCLC and evaluated its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing-Jing, Zhang, Jian-Feng, Yao, Su-Mei, Huang, Hua, Zhang, Shu, Zhao, Minxing, Huang, Jian-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588111/ https://www.ncbi.nlm.nih.gov/pubmed/28927035 http://dx.doi.org/10.3892/ol.2017.6567

Ejemplares similares

Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
por: Lai, John, et al.
Publicado: (2014)

Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability
por: Wei, Xi, et al.
Publicado: (2018)

Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation
por: Yao, Sumei, et al.
Publicado: (2018)

The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients: A meta-analysis
por: Cheng, Fei, et al.
Publicado: (2019)

Identification of speckle-type POZ protein somatic mutations in African American prostate cancer
por: Buckles, Eric, et al.
Publicado: (2014)

Speckle-type POZ protein mutations in prostate cancer: a new part of the mosaic
por: Stoehr, Robert
Publicado: (2015)

Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer
por: Zhi, Xiaofei, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
por: He, Yan, et al.
Publicado: (2021)

The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1
por: Wei, Chunli, et al.
Publicado: (2022)

Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma
por: Chen, Zhi, et al.
Publicado: (2022)

RNA interference-mediated silencing of speckle-type POZ protein promotes apoptosis of renal cell cancer cells
por: Liu, Xiaoxia, et al.
Publicado: (2016)

Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1
por: Shi, Junlin, et al.
Publicado: (2021)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients
por: Fan, Jiye, et al.
Publicado: (2017)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma
por: Deng, Jun, et al.
Publicado: (2022)

Schwann cell Miz without POZ: degeneration meets regeneration
por: Fuhrmann, David, et al.
Publicado: (2015)

Control of inflorescence architecture in tomato by BTB/POZ transcriptional regulators
por: Xu, Cao, et al.
Publicado: (2016)

Backbone resonance assignment of the BCL6-BTB/POZ domain
por: Lin, Li-Ying, et al.
Publicado: (2017)

Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients
por: Yang, Xiao-bo, et al.
Publicado: (2013)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

Nac1 interacts with the POZ-domain transcription factor, Miz1
por: Stead, Mark A., et al.
Publicado: (2014)

Novel genes and alleles of the BTB/POZ protein family in Oryza rufipogon
por: Mandal, Swarupa Nanda, et al.
Publicado: (2023)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
por: Feng, Jian, et al.
Publicado: (2012)

Decreased Expression of the GATA3 Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma
por: Keshari, Rajiv Prasad, et al.
Publicado: (2014)

Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma
por: Shi, Minxing, et al.
Publicado: (2020)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Wang, Dan-dan, et al.
Publicado: (2012)

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2016)

Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma
por: Chiou, Jean, et al.
Publicado: (2017)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer
por: Shi, Hui, et al.
Publicado: (2018)

BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Involvement of CHP2 in the Development of Non–Small Cell Lung Cancer and Patients’ Poor Prognosis
por: Xu, Liqin, et al.
Publicado: (2020)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes
por: Zhang, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t210c1els1una0n8a6glcdsn2f